These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 35303065

  • 41. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S, Katkov W, Cooley J, Kemp JA, Johnston DE, Schapiro RH, Podolsky D.
    Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
    [Abstract] [Full Text] [Related]

  • 42. 6-thioguanine--efficacy and safety in chronic active Crohn's disease.
    Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF.
    Aliment Pharmacol Ther; 2003 Feb 15; 17(4):503-8. PubMed ID: 12622758
    [Abstract] [Full Text] [Related]

  • 43. Thiopurines in the Management of Crohn's Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity-A Retrospective Study.
    Benmassaoud A, Xie X, AlYafi M, Theoret Y, Bitton A, Afif W, Bessissow T.
    Can J Gastroenterol Hepatol; 2016 Feb 15; 2016():1034834. PubMed ID: 27446822
    [Abstract] [Full Text] [Related]

  • 44. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
    Peyrin-Biroulet L, Salleron J, Filippi J, Reenaers C, Antunes O, Filipe V, Louis E, Hébuterne X, Roblin X.
    J Crohns Colitis; 2016 May 15; 10(5):516-24. PubMed ID: 26802084
    [Abstract] [Full Text] [Related]

  • 45. Efficacy of parenteral methotrexate in refractory Crohn's disease.
    Chong RY, Hanauer SB, Cohen RD.
    Aliment Pharmacol Ther; 2001 Jan 15; 15(1):35-44. PubMed ID: 11136276
    [Abstract] [Full Text] [Related]

  • 46. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Townsend CM, Parker CE, MacDonald JK.
    Cochrane Database Syst Rev; 2016 Oct 26; 10(10):CD000545. PubMed ID: 27783843
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Huang Z, Chao K, Li M, Zhi M, Tang J, Hu P, Gao X.
    Inflamm Bowel Dis; 2017 Mar 26; 23(3):440-447. PubMed ID: 28129286
    [Abstract] [Full Text] [Related]

  • 50. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM.
    J Crohns Colitis; 2014 Feb 26; 8(2):120-8. PubMed ID: 23932783
    [Abstract] [Full Text] [Related]

  • 51. Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.
    Thomsen SB, Allin KH, Burisch J, Jensen CB, Hansen S, Gluud LL, Theede K, Kiszka-Kanowitz M, Nielsen AM, Jess T.
    United European Gastroenterol J; 2020 Feb 26; 8(1):68-76. PubMed ID: 32213059
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease.
    Zelinkova Z, Bultman E, Vogelaar L, Bouziane C, Kuipers EJ, van der Woude CJ.
    World J Gastroenterol; 2012 Dec 21; 18(47):6967-73. PubMed ID: 23322995
    [Abstract] [Full Text] [Related]

  • 55. Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.
    Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV.
    World J Gastroenterol; 2014 Jul 21; 20(27):9185-90. PubMed ID: 25083093
    [Abstract] [Full Text] [Related]

  • 56. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D, Macdonald JK, Chande N.
    Cochrane Database Syst Rev; 2014 Feb 21; (2):CD010410. PubMed ID: 24558033
    [Abstract] [Full Text] [Related]

  • 57. Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy.
    Ong DE, Kamm MA, Hartono JL, Lust M.
    J Gastroenterol Hepatol; 2013 Oct 21; 28(10):1595-9. PubMed ID: 23662928
    [Abstract] [Full Text] [Related]

  • 58. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Wang Y, MacDonald JK, Hanauer S.
    Cochrane Database Syst Rev; 2016 Jul 03; 7(7):CD008870. PubMed ID: 27372735
    [Abstract] [Full Text] [Related]

  • 59. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK, McDonald JW.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD006097. PubMed ID: 16856112
    [Abstract] [Full Text] [Related]

  • 60. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW.
    N Engl J Med; 2000 Jun 01; 342(22):1627-32. PubMed ID: 10833208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.